BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 12385583)

  • 1. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific N-ras mutation in rat 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.
    Osaka M; Koh T; Matsuo S; Sugiyama T
    Leukemia; 1997 Apr; 11 Suppl 3():393-5. PubMed ID: 9209402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific N-ras mutation in bone marrow within 48 H of 7,12-dimethylbenz[a]anthracene treatment in Huggins-Sugiyama rat leukemogenesis.
    Osaka M; Matsuo S; Koh T; Sugiyama T
    Mol Carcinog; 1996 Jul; 16(3):126-31. PubMed ID: 8688147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia.
    Osaka M; Matsuo S; Koh T; Sugiyama T
    Mol Carcinog; 1997 Apr; 18(4):206-12. PubMed ID: 9142215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
    Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of DMBA-induced early in vivo ras expression.
    Gyöngyi Z; Grama L; Nádasi E; Sándor J; Németh A; Varga C; Kiss I; Ember I
    In Vivo; 2002; 16(5):323-6. PubMed ID: 12494871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-ras mutations in radiation-induced murine leukemic cells.
    Rithidech KN; Dunn JJ; Gordon CR; Cronkite EP; Bond VP
    Blood Cells Mol Dis; 1996; 22(3):271-80. PubMed ID: 9075579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors.
    Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM
    Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
    Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
    Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations.
    Gansauge S; Schmid RM; Muller J; Adler G; Mattfeldt T; Beger HG
    Br J Surg; 1998 Mar; 85(3):337-40. PubMed ID: 9529487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
    Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
    Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
    Zhang X; Fu Y; Liu S; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2',3'-dideoxycytidine-induced lymphomas.
    Zhuang SM; Cochran C; Goodrow T; Wiseman RW; Söderkvist P
    Cancer Res; 1997 Jul; 57(13):2710-4. PubMed ID: 9205081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.